IGM Biosciences Ownership 2024 | Who Owns IGM Biosciences Now?
Institutional Ownership
38.13%
Insider Ownership
34.45%
Retail Ownership
27.42%
Institutional Holders
88.00
IGM Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 6.83% | 0.49% | 4,088,322 | 397,311 | 10.76% | 39,452,307 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.50% | 0.00% | 3,888,023 | 628,001 | 19.26% | 37,520,000 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 5.15% | 0.76% | 3,080,422 | -20,000 | -0.65% | 29,726,072 | Mar 31, 2024 |
| REDMILE GROUP, LLC | 5.14% | 1.09% | 3,072,478 | 100,936 | 3.40% | 29,649,413 | Mar 31, 2024 |
| FMR LLC | 2.20% | 0.00% | 1,317,341 | -381,165 | -22.44% | 12,712,337 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 2.14% | 0.00% | 1,278,619 | 238,110 | 22.88% | 12,338,673 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 1.57% | 0.01% | 937,500 | - | - | 9,046,875 | Mar 31, 2024 |
| VANGUARD GROUP INC | 1.43% | 0.00% | 853,658 | -43,491 | -4.85% | 8,237,800 | Mar 31, 2024 |
| BLACKROCK INC. | 1.27% | 0.00% | 757,963 | -4,507 | -0.59% | 7,314,344 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.16% | 0.00% | 695,061 | 447,865 | 181.18% | 6,707,339 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.56% | 0.00% | 336,005 | 9,349 | 2.86% | 3,242,834 | Mar 31, 2024 |
| STATE STREET CORP | 0.53% | 0.00% | 319,269 | 11,801 | 3.84% | 3,080,946 | Mar 31, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.33% | 0.18% | 195,000 | -5,000 | -2.50% | 1,881,750 | Mar 31, 2024 |
| TD ASSET MANAGEMENT INC | 0.27% | 0.00% | 159,122 | 75,670 | 90.67% | 1,535,527 | Mar 31, 2024 |
| SAMSARA BIOCAPITAL, LLC | 0.26% | 0.23% | 154,664 | - | - | 1,492,508 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 0.23% | 0.00% | 137,236 | 440 | 0.32% | 1,324,327 | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.20% | 0.00% | 121,118 | 301 | 0.25% | 1,168,789 | Mar 31, 2024 |
| MORGAN STANLEY | 0.17% | 0.00% | 101,095 | 6,054 | 6.37% | 975,568 | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | 0.16% | 0.00% | 93,163 | 45,918 | 97.19% | 899,023 | Mar 31, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.13% | 0.00% | 78,580 | 78,580 | 100.00% | 758,297 | Mar 31, 2024 |
IGM Biosciences's largest institutional shareholder is BAKER BROS. ADVISORS LP, holding 6.83% of the company's total share outstanding, currently valued at $39.45M. The top 10 institutional shareholders own together 33.38% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 5.14% | 1.09% | 3,072,478 | 100,936 | 3.40% | 29,649,413 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 5.15% | 0.76% | 3,080,422 | -20,000 | -0.65% | 29,726,072 | Mar 31, 2024 |
| BAKER BROS. ADVISORS LP | 6.83% | 0.49% | 4,088,322 | 397,311 | 10.76% | 39,452,307 | Mar 31, 2024 |
| EAGLE BAY ADVISORS LLC | 0.07% | 0.27% | 44,635 | - | - | 430,728 | Mar 31, 2024 |
| SAMSARA BIOCAPITAL, LLC | 0.26% | 0.23% | 154,664 | - | - | 1,492,508 | Mar 31, 2024 |
| BRUCE & CO., INC. | 0.11% | 0.21% | 65,000 | - | - | 627,250 | Mar 31, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.33% | 0.18% | 195,000 | -5,000 | -2.50% | 1,881,750 | Mar 31, 2024 |
| PENNANT INVESTORS, LP | 0.11% | 0.16% | 64,900 | - | - | 626,285 | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.03% | 0.14% | 15,801 | 15,801 | 100.00% | 152,480 | Mar 31, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.02% | 0.07% | 13,332 | -911 | -6.40% | 128,654 | Mar 31, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.04% | 1,600 | 1,600 | 100.00% | 15,440,000 | Mar 31, 2024 |
| PALE FIRE CAPITAL SE | 0.02% | 0.02% | 11,601 | - | - | 111,950 | Mar 31, 2024 |
| XTX TOPCO LTD | 0.02% | 0.02% | 11,941 | 11,941 | 100.00% | 115,231 | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.03% | 0.01% | 18,398 | 18,398 | 100.00% | 178,000 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 1.57% | 0.01% | 937,500 | - | - | 9,046,875 | Mar 31, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.05% | 0.01% | 27,731 | 27,731 | 100.00% | 267,604 | Mar 31, 2024 |
| QUEST PARTNERS LLC | 0.01% | 0.01% | 6,952 | 6,952 | 100.00% | 67,087 | Mar 31, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.01% | 0.01% | 4,000 | 4,000 | 100.00% | 38,600 | Mar 31, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.05% | 0.01% | 27,935 | 8,887 | 46.66% | 269,573 | Mar 31, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 0.05% | 0.01% | 30,209 | 30,209 | 100.00% | 291,517 | Mar 31, 2024 |
The largest IGM Biosciences shareholder by % of total assets is REDMILE GROUP, LLC. The company owns 3.07M shares of IGM Biosciences (IGMS), representing 1.09% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.50% | 0.00% | 3,888,023 | 628,001 | 19.26% | 37,520,000 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.16% | 0.00% | 695,061 | 447,865 | 181.18% | 6,707,339 | Mar 31, 2024 |
| BAKER BROS. ADVISORS LP | 6.83% | 0.49% | 4,088,322 | 397,311 | 10.76% | 39,452,307 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 2.14% | 0.00% | 1,278,619 | 238,110 | 22.88% | 12,338,673 | Mar 31, 2024 |
| REDMILE GROUP, LLC | 5.14% | 1.09% | 3,072,478 | 100,936 | 3.40% | 29,649,413 | Mar 31, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.13% | 0.00% | 78,580 | 78,580 | 100.00% | 758,297 | Mar 31, 2024 |
| TD ASSET MANAGEMENT INC | 0.27% | 0.00% | 159,122 | 75,670 | 90.67% | 1,535,527 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.12% | 0.00% | 70,776 | 70,776 | 100.00% | 682,988 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.10% | 0.00% | 57,190 | 57,190 | 100.00% | 551,884 | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | 0.16% | 0.00% | 93,163 | 45,918 | 97.19% | 899,023 | Mar 31, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 0.05% | 0.01% | 30,209 | 30,209 | 100.00% | 291,517 | Mar 31, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.05% | 0.01% | 27,731 | 27,731 | 100.00% | 267,604 | Mar 31, 2024 |
| TREXQUANT INVESTMENT LP | 0.04% | 0.00% | 24,177 | 24,177 | 100.00% | 233,308 | Mar 31, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.12% | 0.00% | 70,501 | 21,559 | 44.05% | 680,335 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.03% | 0.00% | 20,323 | 20,323 | 100.00% | 196,000 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.03% | 0.00% | 20,050 | 20,050 | 100.00% | 193,483 | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.03% | 0.01% | 18,398 | 18,398 | 100.00% | 178,000 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.03% | 0.00% | 17,335 | 17,335 | 100.00% | 167,283 | Mar 31, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.03% | 0.00% | 17,107 | 17,107 | 100.00% | 165,083 | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.03% | 0.14% | 15,801 | 15,801 | 100.00% | 152,480 | Mar 31, 2024 |
As of Mar 31 2024, IGM Biosciences's largest institutional buyer is PRICE T ROWE ASSOCIATES INC /MD/. The company purchased 628.00K stocks of IGMS, valued at $37.52M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -400,000 | -100.00% | - | Mar 31, 2024 |
| FMR LLC | 2.20% | 0.00% | 1,317,341 | -381,165 | -22.44% | 12,712,337 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.02% | - | 13,163 | -198,345 | -93.78% | 127,023 | Mar 31, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -135,596 | -100.00% | - | Mar 31, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -124,260 | -100.00% | - | Mar 31, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -65,870 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | 1.43% | 0.00% | 853,658 | -43,491 | -4.85% | 8,237,800 | Mar 31, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -29,600 | -100.00% | - | Mar 31, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -29,421 | -100.00% | - | Mar 31, 2024 |
| ARTAL GROUP S.A. | 5.15% | 0.76% | 3,080,422 | -20,000 | -0.65% | 29,726,072 | Mar 31, 2024 |
| AMUNDI | - | - | - | -9,196 | -100.00% | - | Mar 31, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.07% | 0.00% | 40,749 | -9,074 | -18.21% | 393,228 | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -8,367 | -100.00% | - | Mar 31, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.04% | 0.00% | 23,319 | -6,954 | -22.97% | 225,028 | Mar 31, 2024 |
| DEUTSCHE BANK AG\ | 0.01% | - | 5,547 | -6,155 | -52.60% | 53,529 | Mar 31, 2024 |
| BARCLAYS PLC | 0.03% | 0.00% | 19,054 | -5,516 | -22.45% | 184,000 | Mar 31, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 302 | -5,411 | -94.71% | 3,000 | Mar 31, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.33% | 0.18% | 195,000 | -5,000 | -2.50% | 1,881,750 | Mar 31, 2024 |
| JANE STREET GROUP, LLC | 0.05% | 0.00% | 31,120 | -4,515 | -12.67% | 300,308 | Mar 31, 2024 |
| BLACKROCK INC. | 1.27% | 0.00% | 757,963 | -4,507 | -0.59% | 7,314,344 | Mar 31, 2024 |
As of Mar 31 2024, IGM Biosciences's biggest institutional seller is ADAGE CAPITAL PARTNERS GP, L.L.C.. The company sold -0.40M shares of IGMS, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP | 0.12% | 0.00% | 70,776 | 70,776 | 100.00% | 682,988 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.10% | 0.00% | 57,190 | 57,190 | 100.00% | 551,884 | Mar 31, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 0.05% | 0.01% | 30,209 | 30,209 | 100.00% | 291,517 | Mar 31, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.05% | 0.01% | 27,731 | 27,731 | 100.00% | 267,604 | Mar 31, 2024 |
| TREXQUANT INVESTMENT LP | 0.04% | 0.00% | 24,177 | 24,177 | 100.00% | 233,308 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.03% | 0.00% | 20,050 | 20,050 | 100.00% | 193,483 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.03% | 0.00% | 17,335 | 17,335 | 100.00% | 167,283 | Mar 31, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.03% | 0.00% | 17,107 | 17,107 | 100.00% | 165,083 | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.03% | 0.14% | 15,801 | 15,801 | 100.00% | 152,480 | Mar 31, 2024 |
| CERITY PARTNERS LLC | 0.02% | 0.00% | 10,513 | 10,513 | 100.00% | 101,451 | Mar 31, 2024 |
| CAPTRUST FINANCIAL ADVISORS | 0.02% | 0.00% | 10,200 | 10,200 | 100.00% | 98,430 | Mar 31, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.01% | 0.00% | 7,248 | 7,248 | 100.00% | 69,943 | Mar 31, 2024 |
| QUEST PARTNERS LLC | 0.01% | 0.01% | 6,952 | 6,952 | 100.00% | 67,087 | Mar 31, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.01% | 0.01% | 4,000 | 4,000 | 100.00% | 38,600 | Mar 31, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.04% | 1,600 | 1,600 | 100.00% | 15,440,000 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.00% | - | 1,100 | 1,100 | 100.00% | 10,615 | Mar 31, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | 0.00% | 0.00% | 749 | 749 | 100.00% | 7,228 | Mar 31, 2024 |
| HANSEATIC MANAGEMENT SERVICES INC | 0.00% | 0.01% | 366 | 366 | 100.00% | 3,532 | Mar 31, 2024 |
| GAMMA INVESTING LLC | 0.00% | 0.00% | 76 | 76 | 100.00% | 733 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 3 | 3 | 100.00% | 28 | Mar 31, 2024 |
IGM Biosciences's largest new institutional shareholder by number of shares is MARSHALL WACE, LLP, purchased 70.78K shares, valued at $682.99K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -400,000 | -100.00% | - | Mar 31, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -135,596 | -100.00% | - | Mar 31, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -124,260 | -100.00% | - | Mar 31, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -65,870 | -100.00% | - | Mar 31, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -29,600 | -100.00% | - | Mar 31, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -29,421 | -100.00% | - | Mar 31, 2024 |
| AMUNDI | - | - | - | -9,196 | -100.00% | - | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -8,367 | -100.00% | - | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -1,810 | -100.00% | - | Mar 31, 2024 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | - | - | - | -500 | -100.00% | - | Mar 31, 2024 |
IGM Biosciences's largest sold out institutional shareholder by shares sold is ADAGE CAPITAL PARTNERS GP, L.L.C., sold -0.40M shares, valued at -, as of undefined.
IGM Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price New Horizons Fund, Inc. | 0.13% | 1,866,490 | -5,966 | -0.32% | Dec 31, 2023 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.09% | 438,971 | -9,127 | -2.04% | Dec 31, 2023 |
| ALGER FUNDS | 0.06% | 62,152 | - | - | Jan 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.06% | 209,619 | - | - | Dec 31, 2023 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.05% | 392,244 | - | - | Dec 31, 2023 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.04% | 151,515 | - | - | Dec 31, 2023 |
| Humankind Benefit Corp | 0.03% | 717 | - | - | Dec 31, 2023 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.03% | 95,175 | - | - | Mar 31, 2024 |
| BRUCE FUND INC | 0.03% | 65,000 | -55,000 | -45.83% | Dec 31, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,539,782 | -148,700 | -8.81% | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 8,083 | - | - | Dec 31, 2023 |
| T. Rowe Price Equity Series, Inc. | 0.02% | 25,767 | - | - | Dec 31, 2023 |
| IndexIQ ETF Trust | 0.01% | 21,441 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.01% | 12,625 | 2,716 | 27.41% | Jan 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.01% | 17,780 | - | - | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.01% | 55,100 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.01% | 107,703 | - | - | Dec 31, 2023 |
| ACAP Strategic Fund | 0.01% | 73,366 | - | - | Dec 31, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,804 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 21,795 | - | - | Dec 31, 2023 |
| UBS FUNDS | 0.00% | 15,791 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.00% | 1,058,229 | 281,225 | 36.19% | Dec 31, 2023 |
| VICTORY PORTFOLIOS | 0.00% | 59,410 | - | - | Dec 31, 2023 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 32,762 | - | - | Feb 29, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 5,676 | - | - | Feb 29, 2024 |
| Nushares ETF Trust | 0.00% | 10,458 | - | - | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,140 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 22,410 | 3,589 | 19.07% | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 4,399 | - | - | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 229 | - | - | Dec 31, 2023 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 11,332 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 156,391 | -5,521 | -3.41% | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 4,636 | - | - | Aug 31, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 86,712 | 17,817 | 25.86% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 5,265 | -334 | -5.97% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 66,122 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 9,841 | - | - | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 627 | - | - | Dec 31, 2023 |
| NEW COVENANT FUNDS | 0.00% | 1,084 | - | - | Dec 31, 2023 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 2,100 | 2,100 | - | Dec 29, 2023 |
| VANGUARD WORLD FUND | 0.00% | 55,909 | 10,351 | 22.72% | Feb 29, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 4,585 | - | - | Dec 31, 2023 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 6,611 | 4,614 | 231.05% | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 344 | -219 | -38.90% | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 539 | - | - | Dec 31, 2023 |
| SunAmerica Specialty Series | 0.00% | 59 | - | - | Apr 30, 2021 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 5,239 | - | - | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,037 | 377 | 57.12% | Dec 31, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 8,321 | 5,310 | 176.35% | Feb 29, 2024 |
| FLEXSHARES TRUST | 0.00% | 4,654 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 4,900 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 64,309 | -376 | -0.58% | Dec 31, 2023 |
| Victory Portfolios II | 0.00% | 3,117 | - | - | Dec 31, 2023 |
| Meeder Funds | 0.00% | 247 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 18,430 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 2,670 | - | - | Feb 29, 2024 |
| GPS Funds I | 0.00% | 186 | - | - | Dec 31, 2023 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,919 | - | - | Dec 31, 2023 |
| RUSSELL INVESTMENT CO | 0.00% | 10,321 | - | - | Jan 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 774 | - | - | Dec 31, 2023 |
| GOLDMAN SACHS TRUST | 0.00% | 5,316 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 495,578 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 58,625 | 12,427 | 26.90% | Feb 29, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 1,772 | - | - | Dec 31, 2023 |
| RYDEX SERIES FUNDS | 0.00% | 109 | - | - | Dec 31, 2023 |
| VANGUARD WELLINGTON FUND | 0.00% | 10,348 | - | - | Feb 29, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 94,350 | 16,200 | 20.73% | Dec 29, 2023 |
| ProFunds | 0.00% | 189 | 77 | 68.75% | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,536 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 5,099 | 502 | 10.92% | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 15,876 | 1,635 | 11.48% | Dec 29, 2023 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 4,916 | -374 | -7.07% | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 584,389 | - | - | Dec 31, 2023 |
| TRANSAMERICA SERIES TRUST | 0.00% | 13,760 | - | - | Dec 31, 2023 |
| Pacer Funds Trust | 0.00% | 617 | - | - | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 54 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 1,799 | -1,276 | -41.50% | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 1,259 | - | - | Feb 29, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 100 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 22,768 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 300 | - | - | Dec 29, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,630 | 148 | 4.25% | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,282 | -18 | -1.38% | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 251 | - | - | Dec 31, 2023 |
| Guggenheim Active Allocation Fund | 0.00% | 48 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 1,946 | -1,686 | -46.42% | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 13,551 | - | - | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 6,399 | - | - | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 7 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 68 | 24 | 54.55% | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 10,200 | - | - | Dec 31, 2023 |
| SPDR INDEX SHARES FUNDS | 0.00% | 747 | - | - | Dec 31, 2023 |
| Brinker Capital Destinations Trust | 0.00% | 239 | 239 | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 297 | - | - | Feb 29, 2024 |
| T. Rowe Price Multi-Strategy Total Return Fund, Inc. | 0.00% | 442 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 2,211 | -16,584 | -88.24% | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 5,467 | - | - | Dec 31, 2023 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 299 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 16,325 | - | - | Feb 29, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 312 | - | - | Dec 31, 2023 |
IGM Biosciences's largest mutual fund holder by % of total assets is "T. Rowe Price New Horizons Fund, Inc.", owning 1.87M shares, compromising 0.13% of its total assets.
IGM Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 88 | 22.22% |
| 31 Dec, 23 | 72 | -11.11% |
| 30 Sep, 23 | 81 | 1.25% |
| 30 Jun, 23 | 80 | 3.90% |
| 31 Mar, 23 | 77 | -8.33% |
| 31 Dec, 22 | 84 | -9.68% |
| 30 Sep, 22 | 93 | 2.20% |
| 30 Jun, 22 | 91 | -14.95% |
| 31 Mar, 22 | 107 | 22.99% |
| 31 Dec, 21 | 87 | -24.35% |
| 30 Sep, 21 | 115 | 6.48% |
| 30 Jun, 21 | 108 | -7.69% |
| 31 Mar, 21 | 117 | 6.36% |
| 31 Dec, 20 | 110 | 12.24% |
| 30 Sep, 20 | 98 | 22.50% |
| 30 Jun, 20 | 80 | 29.03% |
| 31 Mar, 20 | 62 | 24.00% |
| 31 Dec, 19 | 50 | 51.52% |
| 30 Sep, 19 | 33 | - |
As of 31 Mar 24, 88 institutions are holding IGM Biosciences's shares, representing an increase of 22.22% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 22,815,546 | 4.34% |
| 31 Dec, 23 | 21,865,744 | -2.02% |
| 30 Sep, 23 | 22,316,970 | 0.45% |
| 30 Jun, 23 | 22,217,363 | 24.46% |
| 31 Mar, 23 | 17,850,754 | -0.70% |
| 31 Dec, 22 | 17,976,799 | 1.63% |
| 30 Sep, 22 | 17,687,867 | 1.07% |
| 30 Jun, 22 | 17,501,332 | -4.00% |
| 31 Mar, 22 | 18,229,999 | 3.57% |
| 31 Dec, 21 | 17,600,844 | 4.39% |
| 30 Sep, 21 | 16,860,697 | 3.27% |
| 30 Jun, 21 | 16,326,250 | -9.25% |
| 31 Mar, 21 | 17,990,451 | 4.79% |
| 31 Dec, 20 | 17,168,697 | 17.15% |
| 30 Sep, 20 | 14,655,301 | 4.55% |
| 30 Jun, 20 | 14,016,992 | 5.61% |
| 31 Mar, 20 | 13,271,932 | 8.82% |
| 31 Dec, 19 | 12,196,539 | 21.54% |
| 30 Sep, 19 | 10,035,118 | - |
IGM Biosciences (IGMS) has 22.82M shares outstanding as of 31 Mar 24, up 4.34% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 38.13% | 2.83% |
| 31 Dec, 23 | 36.70% | 1.50% |
| 30 Sep, 23 | 49.46% | 1.98% |
| 30 Jun, 23 | 49.96% | 3.10% |
| 31 Mar, 23 | 40.14% | 2.14% |
| 31 Dec, 22 | 43.27% | 2.68% |
| 30 Sep, 22 | 40.17% | 2.53% |
| 30 Jun, 22 | 39.85% | 1.37% |
| 31 Mar, 22 | 53.87% | 1.95% |
| 31 Dec, 21 | 52.57% | 2.07% |
| 30 Sep, 21 | 50.42% | 2.11% |
| 30 Jun, 21 | 48.92% | 1.68% |
| 31 Mar, 21 | 53.98% | 1.79% |
| 31 Dec, 20 | 54.86% | 2.40% |
| 30 Sep, 20 | 47.82% | 2.27% |
| 30 Jun, 20 | 45.88% | 2.42% |
| 31 Mar, 20 | 43.53% | 2.72% |
| 31 Dec, 19 | 40.02% | 3.69% |
| 30 Sep, 19 | 32.92% | - |
As of 31 Mar 24, IGM Biosciences is held by 38.13% institutional shareholders, representing a 2.83% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 48 | 33.33% |
| 31 Dec, 23 | 36 | -14.29% |
| 30 Sep, 23 | 42 | -25.00% |
| 30 Jun, 23 | 56 | 51.35% |
| 31 Mar, 23 | 37 | -11.90% |
| 31 Dec, 22 | 42 | -8.70% |
| 30 Sep, 22 | 46 | -2.13% |
| 30 Jun, 22 | 47 | -26.56% |
| 31 Mar, 22 | 64 | 33.33% |
| 31 Dec, 21 | 48 | -2.04% |
| 30 Sep, 21 | 49 | -14.04% |
| 30 Jun, 21 | 57 | -1.72% |
| 31 Mar, 21 | 58 | -3.33% |
| 31 Dec, 20 | 60 | 42.86% |
| 30 Sep, 20 | 42 | -31.15% |
| 30 Jun, 20 | 61 | 69.44% |
| 31 Mar, 20 | 36 | -7.69% |
| 31 Dec, 19 | 39 | 18.18% |
| 30 Sep, 19 | 33 | - |
48 institutional shareholders have increased their position in IGMS stock as of 31 Mar 24 compared to 36 in the previous quarter (a 33.33% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 21 | - |
| 31 Dec, 23 | 21 | -4.55% |
| 30 Sep, 23 | 22 | 37.50% |
| 30 Jun, 23 | 16 | -38.46% |
| 31 Mar, 23 | 26 | 13.04% |
| 31 Dec, 22 | 23 | -17.86% |
| 30 Sep, 22 | 28 | 3.70% |
| 30 Jun, 22 | 27 | 58.82% |
| 31 Mar, 22 | 17 | -19.05% |
| 31 Dec, 21 | 21 | -34.38% |
| 30 Sep, 21 | 32 | -3.03% |
| 30 Jun, 21 | 33 | -8.33% |
| 31 Mar, 21 | 36 | 5.88% |
| 31 Dec, 20 | 34 | -5.56% |
| 30 Sep, 20 | 36 | 200.00% |
| 30 Jun, 20 | 12 | -29.41% |
| 31 Mar, 20 | 17 | 325.00% |
| 31 Dec, 19 | 4 | - |
| 30 Sep, 19 | - | - |
21 institutional shareholders have reduced their position in IGMS stock as of 31 Mar 24 compared to 21 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 88 | 22.22% | 22,815,546 | 4.34% | 38.13% | 2.83% | 48 | 33.33% | 21 | - |
| 31 Dec, 23 | 72 | -11.11% | 21,865,744 | -2.02% | 36.70% | 1.50% | 36 | -14.29% | 21 | -4.55% |
| 30 Sep, 23 | 81 | 1.25% | 22,316,970 | 0.45% | 49.46% | 1.98% | 42 | -25.00% | 22 | 37.50% |
| 30 Jun, 23 | 80 | 3.90% | 22,217,363 | 24.46% | 49.96% | 3.10% | 56 | 51.35% | 16 | -38.46% |
| 31 Mar, 23 | 77 | -8.33% | 17,850,754 | -0.70% | 40.14% | 2.14% | 37 | -11.90% | 26 | 13.04% |
| 31 Dec, 22 | 84 | -9.68% | 17,976,799 | 1.63% | 43.27% | 2.68% | 42 | -8.70% | 23 | -17.86% |
| 30 Sep, 22 | 93 | 2.20% | 17,687,867 | 1.07% | 40.17% | 2.53% | 46 | -2.13% | 28 | 3.70% |
| 30 Jun, 22 | 91 | -14.95% | 17,501,332 | -4.00% | 39.85% | 1.37% | 47 | -26.56% | 27 | 58.82% |
| 31 Mar, 22 | 107 | 22.99% | 18,229,999 | 3.57% | 53.87% | 1.95% | 64 | 33.33% | 17 | -19.05% |
| 31 Dec, 21 | 87 | -24.35% | 17,600,844 | 4.39% | 52.57% | 2.07% | 48 | -2.04% | 21 | -34.38% |
| 30 Sep, 21 | 115 | 6.48% | 16,860,697 | 3.27% | 50.42% | 2.11% | 49 | -14.04% | 32 | -3.03% |
| 30 Jun, 21 | 108 | -7.69% | 16,326,250 | -9.25% | 48.92% | 1.68% | 57 | -1.72% | 33 | -8.33% |
| 31 Mar, 21 | 117 | 6.36% | 17,990,451 | 4.79% | 53.98% | 1.79% | 58 | -3.33% | 36 | 5.88% |
| 31 Dec, 20 | 110 | 12.24% | 17,168,697 | 17.15% | 54.86% | 2.40% | 60 | 42.86% | 34 | -5.56% |
| 30 Sep, 20 | 98 | 22.50% | 14,655,301 | 4.55% | 47.82% | 2.27% | 42 | -31.15% | 36 | 200.00% |
| 30 Jun, 20 | 80 | 29.03% | 14,016,992 | 5.61% | 45.88% | 2.42% | 61 | 69.44% | 12 | -29.41% |
| 31 Mar, 20 | 62 | 24.00% | 13,271,932 | 8.82% | 43.53% | 2.72% | 36 | -7.69% | 17 | 325.00% |
| 31 Dec, 19 | 50 | 51.52% | 12,196,539 | 21.54% | 40.02% | 3.69% | 39 | 18.18% | 4 | - |
| 30 Sep, 19 | 33 | - | 10,035,118 | - | 32.92% | - | 33 | - | - | - |
IGM Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of IGM Biosciences's stock was made by Harler Mary Beth on Apr 23 2024, selling - shares at - per share (valued at -). The last insider buy of IGMS was made by BAKER BROS. ADVISORS LP on Mar 28 2024, buying 89,407 shares at $9.62 per share (worth $860.04K).
IGM Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 33 | 14 | 235.71% |
| Q4 2023 | 22 | 10 | 220.00% |
| Q3 2023 | 8 | 1 | 800.00% |
| Q2 2023 | 52 | 15 | 346.67% |
| Q1 2023 | 10 | 7 | 142.86% |
| Q4 2022 | 14 | 35 | 40.00% |
| Q3 2022 | 12 | 4 | 300.00% |
| Q2 2022 | 28 | 9 | 311.11% |
| Q1 2022 | 43 | 2 | 2150.00% |
| Q4 2021 | 22 | 7 | 314.29% |
| Q3 2021 | 12 | 14 | 85.71% |
| Q2 2021 | 19 | 26 | 73.08% |
| Q1 2021 | 36 | 25 | 144.00% |
| Q4 2020 | 37 | 19 | 194.74% |
| Q3 2020 | 29 | 11 | 263.64% |
| Q2 2020 | 15 | 5 | 300.00% |
| Q1 2020 | 14 | - | - |
| Q4 2019 | 2 | - | - |
| Q3 2019 | 45 | 29 | 155.17% |
| Q2 2003 | - | - | - |
33 total buy trades, and 14 total sell trades (buy/sell ratio of 2.36%) were made by IGM Biosciences's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 8 | 12 | 66.67% |
| Q4 2023 | 12 | 10 | 120.00% |
| Q3 2023 | - | 1 | - |
| Q2 2023 | 10 | 14 | 71.43% |
| Q1 2023 | - | 5 | - |
| Q4 2022 | 1 | 26 | 3.85% |
| Q3 2022 | 3 | 2 | 150.00% |
| Q2 2022 | 14 | 7 | 200.00% |
| Q1 2022 | 3 | 1 | 300.00% |
| Q4 2021 | - | 2 | - |
| Q3 2021 | - | 5 | - |
| Q2 2021 | - | 8 | - |
| Q1 2021 | - | 7 | - |
| Q4 2020 | 8 | 6 | 133.33% |
| Q3 2020 | 17 | 4 | 425.00% |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | 2 | - | - |
| Q3 2019 | 19 | - | - |
| Q2 2003 | - | - | - |
As of Q1 2024, Insider owners conducted 8 open market buy trades and 12 open market sell trades of IGM Biosciences's stocks.
IGM Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| PASG | Passage Bio, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| BCEL | Atreca, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| ERAS | Erasca, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| IKNA | Ikena Oncology, Inc. |
| RNA | Avidity Biosciences, Inc. |
IGMS Ownership FAQ
Who Owns IGM Biosciences?
IGM Biosciences is owned by institutional shareholders (38.13%), insiders (34.45%), and public (27.42%). The largest institutional shareholder of IGM Biosciences is BAKER BROS. ADVISORS LP (6.83% of total shares) and the top mutual fund owner is T. Rowe Price New Horizons Fund, Inc. (0.13% of total shares).
Who are the major institutional shareholders of IGM Biosciences?
IGM Biosciences's major institutional shareholders are BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, ARTAL GROUP S.A., REDMILE GROUP, LLC, and FMR LLC. The top five shareholders own together 25.82% of the company's share outstanding.
How many IGM Biosciences shareholders are there?
As of Mar 2024, there are 88 institutional shareholders of IGM Biosciences.
What percentage of IGM Biosciences is owned by BAKER BROS. ADVISORS LP?
BAKER BROS. ADVISORS LP owns 4.09M shares of IGM Biosciences, representing 6.83% of the company's total shares outstanding, valued at $39.45M (as of Mar 2024).
What percentage of IGM Biosciences is owned by PRICE T ROWE ASSOCIATES INC /MD/?
As of Mar 2024, PRICE T ROWE ASSOCIATES INC /MD/ holds 3.89M shares of IGM Biosciences (IGMS), compromising 6.50% of the company, valued at $37.52M.
What percentage of IGM Biosciences is owned by ARTAL GROUP S.A?
ARTAL GROUP S.A is the third largest holder of IGM Biosciences. The company owns 3.08M of the company's shares outstanding (worth $29.73M).